By | January 27, 2012

All FDA Committee Members Should Get to Speak Out Regarding Yaz

In a previous blog post, we shared a news story regarding the FDA and the recent Yaz, Yasmin vote that has come under scrutiny. Is the FDA in bed with big pharmaceutical companies?… Read More

By | January 20, 2012

FDA’s Recent Yaz, Yasmin Vote Under Scrutiny

A recent MedPage Today article printed in EveryDay Health* reports that four FDA medical advisors voting on the risks versus benefits of birth control medications, like Yaz and Yasmin, had ties to Bayer. These FDA… Read More

By | June 3, 2011

FDA to Review Popular Birth Control Pill Yaz

Women who take birth control know doing so comes with a risk of blood clots, especially if they’re a smoker over 35. However, two new studies by the British Medical Journal found that women… Read More

By | June 1, 2011

Health Risks Underestimated for Popular Smoking-Cessation Drug Chantix

A Pharmaceutical watch dog group has reported that the risks of smoking cessation drug Chantix (Varenicline) have been underestimated in the latest round of the Food & Drug Administration reporting. The Institute for… Read More

By | May 24, 2011

Avandia Pulled From Shelves Months After Dangers Known

The Food & Drug Administration announced last week that it will pull the diabetes drug Avandia and its sister medications Avandamet and Avandaryl from retail pharmacy shelves beginning in November. After Nov. 18, only certified… Read More

By | November 24, 2010

FDA Pulls Darvon, Darvocet from Market for Heart Risks

The maker of the pain killer medicine known as Darvon and Darvocet, or propoxyphene, announced last week it will stop making the popular drugs because it can cause serious heart rhythm abnormalities,… Read More

By | September 1, 2010

New Study Warns Meridia Weight Loss Pill Increases Heart Attack, Stroke Risk

People with heart disease who want to lose weight should avoid taking Abbott’s weight loss pill Meridia, according to a new study funded by the drug’s manufacturer. In Europe, the drug, known… Read More

By | July 18, 2010

Avandia Stays on Market Despite Heart Attack Dangers

In a puzzling turn of events this week, an F.D.A. panel voted 20-12 to leave Avandia, from GlaxoSmithKline, on the market but with restrictions because of heart attack risks. Avandia was once the… Read More

By | June 4, 2010

Antacid drugs linked to increased risk of bone fractures, FDA warns

Take a pill for heartburn and you could fracture a bone. While it won’t happen overnight, the FDA released a warning last week informing consumers that long-term use of such drugs, known as proton… Read More

By | May 26, 2010

Simmons Hanly Conroy Monitors Tylenol Recalls, FDA Investigation

Due to reports of serious side effects, McNeil, a division of Johnson & Johnson, has made four major recalls of over-the-counter products, including Tylenol, Motrin and Benadryl, in the past seven months.… Read More